Literature DB >> 15824299

Concealed renal insufficiency and adverse drug reactions in elderly hospitalized patients.

Andrea Corsonello1, Claudio Pedone, Francesco Corica, Chiara Mussi, Pierugo Carbonin, Raffaele Antonelli Incalzi.   

Abstract

BACKGROUND: Adverse drug reactions (ADRs) are common causes of in-hospital complications for elderly people. The purpose of the present study is to verify whether concealed renal insufficiency, that is, reduction of the estimated glomerular filtration rate (GFR) in people with normal serum creatinine levels, is a risk factor for ADRs in elderly hospitalized patients.
METHODS: We used data on 11,687 hospitalized patients enrolled in the Gruppo Italiano di Farmacovigilanza nell'Anziano study. The outcomes of the study were any ADR, ADR to hydrosoluble drugs, and ADR to any other drug during the hospital stay. We compared 3 groups: normal renal function (normal serum creatinine levels and normal estimated GFRs), concealed (normal serum creatinine levels and reduced estimated GFRs), or overt (increased creatinine levels and reduced estimated GFRs) renal insufficiency. The relationship between renal function and ADR was evaluated using contingency tables and multiple regression analysis including potential confounders.
RESULTS: Concealed renal insufficiency was detected in 1631 (13.9%) patients and was frequently associated with male sex and poor nutritional status. Hydrosoluble drugs were responsible for 301 of the 941 recorded ADRs. After adjusting for potential confounders, both concealed (odds ratio [OR], 1.61; 95% confidence interval [CI], 1.15-1.25) and overt (OR, 2.02; 95% CI, 1.54-2.65) renal failure were associated with ADR to hydrosoluble drugs, but not with ADR to other drugs (OR, 0.83 [95% CI, 0.65-1.08], and OR, 1.01 [95%CI, 0.83-1.23], respectively).
CONCLUSION: Older hospitalized patients frequently have impaired renal function despite normal serum creatinine levels and are exposed to an increased risk of ADRs to hydrosoluble drugs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15824299     DOI: 10.1001/archinte.165.7.790

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  65 in total

1.  Clinical decision support implemented with academic detailing improves prescribing of key renally cleared drugs in the hospital setting.

Authors:  Gregory W Roberts; Christopher J Farmer; Philip C Cheney; Stephen M Govis; Thomas W Belcher; Scott A Walsh; Robert J Adams
Journal:  J Am Med Inform Assoc       Date:  2010 May-Jun       Impact factor: 4.497

Review 2.  Drug therapy in patients with chronic renal failure.

Authors:  Bertram Hartmann; David Czock; Frieder Keller
Journal:  Dtsch Arztebl Int       Date:  2010-09-17       Impact factor: 5.594

Review 3.  Underprescription of beneficial medicines in older people: causes, consequences and prevention.

Authors:  Antonio Cherubini; Andrea Corsonello; Fabrizia Lattanzio
Journal:  Drugs Aging       Date:  2012-06-01       Impact factor: 3.923

4.  Assessing general practitioners' prescribing behaviour in elderly patients with concealed renal failure.

Authors:  Annie Pierre Jonville-Béra; Lucie Paroux; Elisabeth Autret-Leca
Journal:  Br J Clin Pharmacol       Date:  2008-03-13       Impact factor: 4.335

5.  A nurse-led intervention for identification of drug-related problems.

Authors:  Monica Bergqvist; Johanna Ulfvarson; Eva Andersen Karlsson; Christer von Bahr
Journal:  Eur J Clin Pharmacol       Date:  2008-01-19       Impact factor: 2.953

Review 6.  The clinical implications of ageing for rational drug therapy.

Authors:  Shaojun Shi; Klaus Mörike; Ulrich Klotz
Journal:  Eur J Clin Pharmacol       Date:  2008-01-05       Impact factor: 2.953

7.  Factors associated with falls in older adults with cancer: a validated model from the Cancer and Aging Research Group.

Authors:  Tanya M Wildes; Ronald J Maggiore; William P Tew; David Smith; Can-Lan Sun; Harvey Cohen; Supriya G Mohile; Ajeet Gajra; Heidi D Klepin; Cynthia Owusu; Cary P Gross; Hyman Muss; Andrew Chapman; Stuart M Lichtman; Vani Katheria; Arti Hurria
Journal:  Support Care Cancer       Date:  2018-04-28       Impact factor: 3.603

8.  Patient-reported and actionable safety events in CKD.

Authors:  Jennifer S Ginsberg; Min Zhan; Clarissa J Diamantidis; Corinne Woods; Jingjing Chen; Jeffrey C Fink
Journal:  J Am Soc Nephrol       Date:  2014-02-20       Impact factor: 10.121

Review 9.  [Pain therapy for Fabry's disease].

Authors:  C Sommer; N Uçeyler; T Duning; K Arning; R Baron; E Brand; S Canaan-Kühl; M Hilz; D Naleschinski; C Wanner; F Weidemann
Journal:  Internist (Berl)       Date:  2013-01       Impact factor: 0.743

10.  Adverse safety events in chronic kidney disease: the frequency of "multiple hits".

Authors:  Erica Chapin; Min Zhan; Van Doren Hsu; Stephen L Seliger; Loreen D Walker; Jeffrey C Fink
Journal:  Clin J Am Soc Nephrol       Date:  2009-12-03       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.